{
  "id": 2256138,
  "title": "PD-1-Targeted IL-2v Expands a Novel Stem-like T Cell Subset Distinct from Anti-PD-1 Therapy to Enhance Effector Differentiation",
  "url": "https://urgent.news/2026/08/20/pd-1-targeted-il-2v-expands-a-novel-stem-like-t-cell-subset-distinct",
  "topic": "culture",
  "section": "Culture",
  "published": "2026-08-20T00:00:00.000Z",
  "source": {
    "name": "bioRxiv",
    "slug": "biorxiv",
    "url": "https://www.biorxiv.org/content/10.64898/2026.08.17.745170v1?rss=1"
  },
  "original_language": "en",
  "account": "Tumor-draining lymph nodes are essential for the development and differentiation of stem-like CD8 T cells during anti-tumor immune responses. Recent studies have shown that administering interleukin-2 to PD1-stem-like CD8 T cells using PD1-IL2v, an immunocytokine that combines PD-1 blockade with IL-2 receptor stimulation, promotes these cells' transformation into highly effective effector cells with improved tumor-killing abilities. However, it is unclear how targeted interleukin-2 therapies specifically guide early stem-like T-cell differentiation. To address this, researchers used single-cell transcriptomics and T-cell receptor sequencing in murine pancreatic tumor models and found that PD1-IL2v triggers an early split in the differentiation of stem-like CD8 T cells within tumor-draining lymph nodes. These differentiated cells exhibited the expression of interferon-response genes, natural killer cell receptor genes, and Cx3cr1, indicating activation of interleukin-2 and STAT5-associated pathways. Clonal tracking showed a significant presence of these lymph node-derived cells in intratumoral effector populations, suggesting a developmental connection between early priming in lymph nodes and subsequent effector differentiation. In contrast, another stem-like state characterized by exhaustion features, such as heightened Tox expression, emerged when PD-1 therapy was employed. These discoveries shed light on an early decision point in stem-like T-cell differentiation and offer insights into how PD1-IL2v bypasses exhaustion pathways to foster the generation of effective anti-tumor immunity.",
  "summary": "Tumor-draining lymph nodes serve as critical sites for the generation, maintenance and differentiation of stem-like CD8 T cells during antitumor immune responses. Recent evidence has shown that delivering interleukin-2 to PD1 stem-like CD8 T cells using PD1-IL2v, an immunocytokine combining PD-1 blockade and IL-2R agonism, promotes their differentiation into potent effector cells with enhanced…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}